# Hypoglycemia Treatments

This is a subcategory of Endocrine Agents.

## Length of Authorizations

365 Days

## Prior Authorization Criteria

1. Is there any reason the patient cannot be changed to a medication not requiring prior approval within the same class and formulation? Acceptable reasons include:

    - Allergy to medications not requiring prior approval

    - Contraindication to or drug interaction with medications not requiring prior approval

    - History of unacceptable/toxic side effects to medications not requiring prior approval

## Additional Criteria
### Non-Preferred

A non-preferred medication will be approved after a trial with a preferred medication not requiring prior approval or the inability of the member and/or caregiver to administer a preferred glucagon product in a timely fashion.

Quantity limit of 2 per 34 days

## Formulary

Endocrine Agents: Diabetes â€“ Hypoglycemia Treatments

### Preferred

| Preferred                             |
| :------------------------------------ |
| Baqsimi QL                            |
| Glucagen Hypokit                      |
| Glucagon Emerg Kit [Labeler 00002] QL |
| Gvoke Hypopen QL                      |
| Gvoke PFS QL                          |
| Zegalogue                             |

### Non-Preferred

| Non-Preferred                                 |
| :-------------------------------------------- |
| Glucagon Emerg Kit [Labeler 00548 & 63323] QL |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=49)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=19)
